Back to NBYView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Impetigo
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Experimental: CD07223 1.5 % Topical Gel BIDPhase 3
Impetigo
Auriclosene Solution 0.3%Phase 2
Bacterial Conjunctivitis
NVC-422 Solution, 0.3%Phase 2
Adenoviral Conjunctivitis
sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydratePhase 2
Asymptomatic Bacteriuria
NVC-422, 0.2%Phase 2
Urinary Catheter Blockage and Encrustation
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts